Since day one at TGen, our goal has always been to champion the use of an individual’s underlying genetic profile to guide clinical decisions, whether preventing, diagnosing, or treating disease. Matching each patient with the appropriate therapy based upon the underlying biology of his or her specific disease leads to a higher percentage of patient benefit while lessening unnecessary toxicity and time spent on ineffective therapies.